ポイントオブケア＆迅速診断市場：プラットフォーム、サンプル、購入、エンドユーザー別-2025-2030年世界予測

ポイントオブケア＆迅速診断市場は、2023年に484億3,000万米ドルと評価され、2024年には518億5,000万米ドルに達すると予測され、CAGR 7.11％で成長し、2030年には783億4,000万米ドルに達すると予測されています。

ポイント・オブ・ケア（POC）および迅速診断には、患者の治療現場またはその近くで実施される医療検査が含まれ、即座の臨床判断を容易にするために迅速な結果が提供されます。このような診断の必要性は、特に救急医療、農村環境、パンデミック時などにおいて、患者の待ち時間を短縮し転帰を改善するためにタイムリーな診断が求められていることに起因します。POCおよび迅速診断の用途は、ブドウ糖モニタリングや妊娠検査から、COVID-19のような感染症の高度分子診断まで多岐にわたる。最終用途分野は、病院、診療所、在宅医療環境、研究室など多岐にわたる。市場成長の原動力となっているのは、技術の進歩、慢性疾患の増加、ヘルスケアサービスの分散化に対する需要の高まりです。COVID-19の大流行は、迅速検査ソリューションの必要性を著しく拡大し、診断スピードが極めて重要な要因であることを浮き彫りにしました。遠隔医療を拡大し、診断をデジタルヘルスプラットフォームと統合し、より良い患者管理のためのリアルタイムデータ分析を強化することにビジネスチャンスがあります。しかし、高度なPOC機器の高コスト、規制上の制約、ラボベースの診断と比較した場合の精度のばらつきといった制約が課題となっています。さらに、機器の相互運用性やデータの統合といった運用上の問題も、シームレスな普及を妨げています。技術革新の主な分野としては、多項目検査機器の開発、診断精度を高めるための人工知能の搭載、家庭で使用できる携帯型の使いやすいプラットフォームの開発などが挙げられます。市場はダイナミックであり、個別化ケアとプロアクティブな健康管理へのシフトを反映しています。成長を目指す企業は、研究開発協力に投資し、費用対効果の高いソリューションでポートフォリオを多様化し、POC診断薬の利点と正しい使用方法に関する顧客教育を優先すべきです。ヘルスケアプロバイダーとのパートナーシップを通じてアクセスを拡大し、未開拓の地域を開拓することで、市場での存在感をさらに高め、持続的な成長を促すことができると思われます。

市場力学：急速に進化するポイントオブケア＆迅速診断市場の主要市場インサイトを公開

ポイントオブケア＆迅速診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症の急増
  • 分散型ヘルスケアシステムの普及
  • 政府の支援政策
• 市場抑制要因
  • 新しい迅速診断検査に対する認知度の低下と標準的な規制方法の欠如
• 市場機会
  • 多重化機能を備えた革新的なPOC検査
• 市場の課題
  • 検査室での効果的な診断方法の代替

ポーターのファイブフォース：ポイントオブケア＆迅速診断市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ポイントオブケア＆迅速診断市場における外部からの影響の把握

外部マクロ環境要因は、ポイントオブケア＆迅速診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ポイントオブケア＆迅速診断市場における競合情勢の把握

ポイントオブケア＆迅速診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスポイントオブケア＆迅速診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ポイントオブケア＆迅速診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ポイントオブケア＆迅速診断市場における成功への道筋を描く

ポイントオブケア＆迅速診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の蔓延率が高い
    • 分散型ヘルスケアシステムの普及
    • 政府の支援政策
  • 抑制要因
    • 新しい迅速診断検査に対する認知度の低下と標準的な規制方法の欠如
  • 機会
    • 多重化機能を備えた革新的なPOCテスト
  • 課題
    • 研究室での診断の代替効果的な方法
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ポイントオブケア＆迅速診断市場：プラットフォーム別

• ディップスティック
• 免疫測定
• マイクロ流体

第7章 ポイントオブケア＆迅速診断市場サンプル

• 血
• 尿

第8章 ポイントオブケア＆迅速診断市場購入別

• 店頭
• 処方箋

第9章 ポイントオブケア＆迅速診断市場：エンドユーザー別

• ホームケア
• 病院
• 薬局

第10章 南北アメリカのポイントオブケア＆迅速診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のポイントオブケア＆迅速診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのポイントオブケア＆迅速診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Becton, Dickinson and Company
• Binx Health, inc.
• bioMerieux SA
• Cardinal Health, Inc.
• Co-Diagnostics, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Genomadix Inc.
• Lucira Health, Inc.
• Meridian Bioscience Inc. by SD Biosensor
• Novartis AG
• OraSure Technologies, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIPSTICK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 35. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 57. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 61. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 130. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 146. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 150. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Point of Care & Rapid Diagnostics Market was valued at USD 48.43 billion in 2023, expected to reach USD 51.85 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 78.34 billion by 2030.

Point of Care (POC) and Rapid Diagnostics encompass medical testing conducted at or near the site of patient care, delivering quick results to facilitate immediate clinical decisions. The necessity for such diagnostics stems from the demand for timely diagnosis, especially in emergency care, rural settings, and during pandemics, to reduce patient wait times and improve outcomes. Applications of POC and rapid diagnostics range from glucose monitoring and pregnancy tests to advanced molecular diagnostics for infectious diseases like COVID-19. End-use sectors extend across hospitals, clinics, home care settings, and research laboratories. Market growth is fueled by technological advances, rising prevalence of chronic diseases, and an increasing demand for decentralizing healthcare services. The COVID-19 pandemic significantly expanded the need for rapid testing solutions, highlighting diagnostic speed as a pivotal factor. Opportunities lie in expanding telemedicine and integrating diagnostics with digital health platforms, enhancing real-time data analytics for better patient management. However, limitations such as the high cost of sophisticated POC devices, regulatory constraints, and variable accuracy compared to lab-based diagnostics pose challenges. Additionally, operational issues like device interoperability and data integration also hinder seamless adoption. Key areas for innovation include the development of multi-analyte testing devices, incorporating artificial intelligence for enhanced diagnostic accuracy, and advancing portable, user-friendly platforms for home use. The market is dynamic, reflecting a shift towards personalized care and proactive health management, demanding continuous innovation to address emerging healthcare needs. Companies looking to leverage growth should invest in R&D collaborations, diversify portfolio offerings with cost-effective solutions, and prioritize customer education on benefits and correct usage of POC diagnostics. Expanding access through partnerships with healthcare providers and exploring untapped regions would further cement market presence and drive sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High oprevelance of the infectious diseases
  • Proliferation of decentralized healthcare systems
  • Supportive government policies
• Market Restraints
  • Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
• Market Opportunities
  • Innovative POC test with multiplexing capabilities
• Market Challenges
  • Alternate effective ways of diagnosis in laboratories

Porter's Five Forces: A Strategic Tool for Navigating the Point of Care & Rapid Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point of Care & Rapid Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point of Care & Rapid Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point of Care & Rapid Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point of Care & Rapid Diagnostics Market

A detailed market share analysis in the Point of Care & Rapid Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point of Care & Rapid Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point of Care & Rapid Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point of Care & Rapid Diagnostics Market

A strategic analysis of the Point of Care & Rapid Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point of Care & Rapid Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, inc., bioMerieux SA, Cardinal Health, Inc., Co-Diagnostics, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Genomadix Inc., Lucira Health, Inc., Meridian Bioscience Inc. by SD Biosensor, Novartis AG, OraSure Technologies, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Point of Care & Rapid Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Platform, market is studied across Dipstick, Immunoassay, and Microfluidics.
• Based on Sample, market is studied across Blood and Urine.
• Based on Purchase, market is studied across OTC and Prescription.
• Based on End-User, market is studied across Homecare, Hospital, and Pharmacy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High oprevelance of the infectious diseases
    • 5.1.1.2. Proliferation of decentralized healthcare systems
    • 5.1.1.3. Supportive government policies
  • 5.1.2. Restraints
    • 5.1.2.1. Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovative POC test with multiplexing capabilities
  • 5.1.4. Challenges
    • 5.1.4.1. Alternate effective ways of diagnosis in laboratories
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Point of Care & Rapid Diagnostics Market, by Platform

• 6.1. Introduction
• 6.2. Dipstick
• 6.3. Immunoassay
• 6.4. Microfluidics

7. Point of Care & Rapid Diagnostics Market, by Sample

• 7.1. Introduction
• 7.2. Blood
• 7.3. Urine

8. Point of Care & Rapid Diagnostics Market, by Purchase

• 8.1. Introduction
• 8.2. OTC
• 8.3. Prescription

9. Point of Care & Rapid Diagnostics Market, by End-User

• 9.1. Introduction
• 9.2. Homecare
• 9.3. Hospital
• 9.4. Pharmacy

10. Americas Point of Care & Rapid Diagnostics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Point of Care & Rapid Diagnostics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Point of Care & Rapid Diagnostics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Binx Health, inc.
• 4. bioMerieux SA
• 5. Cardinal Health, Inc.
• 6. Co-Diagnostics, Inc.
• 7. Danaher Corporation
• 8. F. Hoffmann-La Roche AG
• 9. Genomadix Inc.
• 10. Lucira Health, Inc.
• 11. Meridian Bioscience Inc. by SD Biosensor
• 12. Novartis AG
• 13. OraSure Technologies, Inc.
• 14. Siemens Healthineers AG
• 15. Thermo Fisher Scientific Inc.